Skip to main content
Canna~Fangled Abstracts

Trends in intellectual property rights protection for medical cannabis and related products

By January 6, 2021February 2nd, 2021No Comments
Specific cannabis patents in agricultural technologies directed at improving yield, efficiency, and quality (known as “agritech”) are being filed and granted.
Review
. 2021 Jan 6;3(1):1.

doi: 10.1186/s42238-020-00057-7.

Joseph Wyse 1, Gilad Luria 2
Affiliations 

Abstract

The purpose of this review is to advance the field of applied cannabis research by providing insights into the patenting of medical cannabis and current intellectual property rights (IPR) data. Medical cannabis (MC) patent and plant breeders’ rights (PBR) registrations are filed on industrially applicable aspects of research. Studying the filing data and trends informs researchers of both gaps in current applied knowledge in MC (where patents have not been filed) and prior knowledge (where patents have already been filed). Our focus is on those intellectual property rights (IPR) that are registered and germane to technical innovations in MC and related products. These are patents and PBR and thus exclude trade secrets, copyrights, franchises, or trademarks. Methods used for surveying the defined IPR landscape include searches of publicly available patent and PBR data and classifying the data according to the upstream-midstream-downstream innovation paradigm of the MC industry.The findings suggest that the technical knowledge as expressed by patent filings is growing commensurate to the economic and legislative activity. Specific cannabis patents in agricultural technologies directed at improving yield, efficiency, and quality (known as “agritech”) are being filed and granted. These agritech-focused patents represent original novel and applied MC research achievements that address specific problems in cannabis cultivation, such as protection of the cannabis crop, maximizing cannabis yield, harvesting and post-harvesting of cannabis, and new advantageous varieties. Patents on ex planta and in planta cannabis genes expression have been published in recent years while patents on extraction methods for cannabinoids have increased since 2015. Much patent activity is in the downstream category of MC patient-oriented products and delivery systems for a very wide range of medical indications and disease conditions. The emerging importance of access and benefit-sharing treaties and regulations is noted with implications on the industry briefly discussed. Patent data on leading and emerging patentee companies and institutions are shown. We also provide evidence of prior art and freedom to operate.

 

Keywords: Access and benefit sharing, CBD, Cannabinoid, Intellectual property rights, Marijuana, Medical cannabis, Nagoya Protocol, Patents, Plant breeders’ rights, THC

References

    1. Bridgeman MB, Abazia DT. Medicinal cannabis: history, pharmacology, and implications for the acute care setting. P T. 2017;4(2):180-88.
    1. CA3050648A1 – Method and apparatus for harvesting trichomes from cannabis plants – Google Patents. https://patents.google.com/patent/CA3050648A1/en?oq=CA3050648A1 .
    1. Cai M. Madey v. Duke University: shattering the myth of universities’ experimental use defense. Berkeley Technol. Law J. 2004;19:175-92.
    1. Clinical Trials register – Search for Cannabis. https://www.clinicaltrialsregister.eu/ctr-search/search?query=Cannabis&p… .
    1. Duvall CS. Drug laws, bioprospecting and the agricultural heritage of Cannabis in Africa. Sp. Polity. 2016. https://doi.org/10.1080/13562576.2016.1138674 .

Publication types

Leave a Reply